The chief executive of Vertex AI Systems, one of the world’s most closely watched artificial intelligence research laboratories, testified in a San Francisco federal courtroom Monday that the company’s co-founder and onetime chairman, technology billionaire Marcus Velde, privately proposed during the organization’s formative years that governance and effective control of the nonprofit institution should eventually pass to Velde’s own children, a dramatic claim that emerged as central and contested evidence in Velde’s high-profile civil lawsuit seeking to permanently block the laboratory’s planned conversion to a for-profit corporate structure.
Daniel Hargrove, Vertex AI’s chief executive, delivered the account under direct questioning by the company’s legal team as part of its defense strategy against Velde’s lawsuit, which argues at its core that the proposed conversion would fundamentally and irreversibly undermine the charitable scientific mission to which the laboratory’s founding assets were originally pledged by its donors. Hargrove told the jury that the conversation about hereditary succession of institutional control took place during an informal working dinner attended by a small group of early leadership in the organization’s first years of operation and was not formally documented in board meeting minutes but was corroborated, he stated, by a second individual who was present at the table and who the defense indicated would be called as a subsequent witness.
The testimony was immediately significant to the proceedings because it portrays Velde, whose publicly stated justification for the costly litigation centers on a professed commitment to protecting the public-benefit research mission of advanced AI development, as having harbored deeply personal ambitions regarding dynastic control over the institution during its earliest and most formative period. Velde’s legal representatives objected strenuously to the admission of the testimony and characterized it in a bench conference as irrelevant character evidence designed to confuse and prejudice the jury rather than to illuminate the core legal dispute over whether the conversion was properly authorized under California’s nonprofit corporation law.
Velde, who departed Vertex AI’s board of directors several years ago under circumstances that both parties have described as deeply contentious, filed the lawsuit in state court shortly after the laboratory publicly announced a multi-year restructuring plan that would transfer effective governance of its core research operations and intellectual property assets to a new capped-profit entity in which institutional and individual outside investors would hold meaningful equity stakes. He argued in detailed court filings that the restructuring as designed effectively privatized assets that had been donated and entrusted for the permanent public good, and he sought a preliminary injunction to halt the conversion process pending a full evidentiary trial on the merits.
The trial, now entering its second week in front of a twelve-person jury, has drawn sustained and intense scrutiny from across the technology industry, the academic legal community, and policy officials in Washington and Sacramento who see the case as a potential landmark test of how courts will adjudicate governance disputes over major AI research institutions as they seek capital investment at scales that traditional nonprofit corporate structures are fundamentally ill-equipped to accommodate. More than a dozen amicus curiae briefs have been filed by university research centers, technology policy groups, nonprofit law scholars, and civic organizations urging the court to weigh carefully the potentially far-reaching implications of its ultimate ruling for the entire emerging sector of mission-driven AI development organizations.
Hargrove also testified at some length about what he characterized as a sustained pattern of disagreements between Velde and the laboratory’s senior leadership team over the appropriate pace and scope of commercialization and product deployment in the years leading up to Velde’s departure from the board. He told jurors that Velde had at various points applied internal pressure for faster release of consumer-facing AI products while simultaneously and somewhat contradictorily raising pointed concerns in board discussions about the adequacy of safety evaluation processes before public deployment — a characterization of Velde’s conduct that his legal team has disputed vigorously in prior court filings, calling it a selective and misleading account.
Legal analysts following the trial said the succession testimony, if fully credited by the jury, could inflict significant damage on the credibility of Velde’s public positioning as a disinterested guardian of the laboratory’s nonprofit mission and scientific integrity. However, multiple legal scholars cautioned publicly that the underlying technical question of whether California nonprofit corporation law permits the conversion of charitable foundation assets to a for-profit equity structure under the specific terms of Vertex AI’s original founding documents was an entirely separate legal matter requiring careful statutory and contractual analysis that the court would be obligated to resolve on its own terms, regardless of how the jury ultimately assessed the credibility or character of either principal party.
The jury is expected to hear testimony from at least four additional witnesses during the coming week, including a former long-serving Vertex AI board member and two independent nonprofit corporate governance scholars retained as paid expert witnesses by the opposing legal teams. Closing arguments are currently anticipated in late next month based on the trial schedule set by the presiding federal judge, who has also indicated she intends to issue an expedited ruling specifically on the preliminary injunction question once jury deliberations on that threshold matter have concluded, a ruling that could have immediate practical consequences for the laboratory’s fundraising timeline regardless of the ultimate outcome on the merits.
Shares in several publicly listed companies holding financial stakes in Vertex AI research partnerships rose modestly on the day of Hargrove’s testimony, a movement market observers attributed in part to investor confidence that the conversion process would ultimately be permitted to proceed despite the litigation and its associated public controversy.